Log in
Donate

Clinical Trial: ALLIANCE A151216

ALLIANCE A151216

Status: Open

NCT#02194738

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
A screening trial for A081105 (closed), A081801, E4512, (Closed) and EA5142 (closed).

Eligible for screening study DCP 001

Effective, August 26, 2019, enrollment is temporarily suspended for patients with squamous histology.

A151216 will closed to accrual effective March 14, 2025, and patients will register directly to A081801.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved